NumerixS Investment Technologies’s Pfizer PFE Stock Holding History

NumerixS Investment Technologies’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-89,496	Closed	-$3.05M	–	1196
2019 Q3	$3.05M	Buy	89,496 +46,223	+107%	+$1.68M	0.79%	16
2019 Q2	$1.78M	Buy	+43,273	New	+$1.72M	0.51%	28
2018 Q3	–	Sell	-8,010	Closed	-$276K	–	1331
2018 Q2	$276K	Sell	8,010 -78,907	-91%	-$2.7M	0.06%	415
2018 Q1	$2.91M	Buy	86,917 +38,433	+79%	+$1.32M	0.72%	19
2017 Q4	$1.67M	Sell	48,484 -35,078	-42%	-$1.2M	0.38%	48
2017 Q3	$2.83M	Buy	83,562 +16,917	+25%	+$544K	0.63%	16
2017 Q2	$2.12M	Sell	66,645 -129,327	-66%	-$4.08M	0.31%	64
2017 Q1	$6.36M	Buy	+195,972	New	+$6.18M	0.73%	16
2016 Q4	–	Sell	-29,256	Closed	-$940K	–	1291
2016 Q3	$940K	Sell	29,256 -29,184	-50%	-$976K	0.12%	206
2016 Q2	$1.95M	Sell	58,440 -217,260	-79%	-$6.93M	0.27%	72
2016 Q1	$7.75M	Buy	+275,700	New	+$7.88M	0.89%	6
2015 Q4	–	Sell	-273,768	Closed	-$8.16M	–	857
2015 Q3	$8.16M	Buy	+273,768	New	+$8.78M	0.93%	14

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

NumerixS Investment Technologies's PFE Position: Q4 2019 in Review

NumerixS Investment Technologies sold out of Pfizer (PFE) in Q4 2019, closing a stake of 89,496 shares — an estimated $3.05M sold.

NumerixS Investment Technologies first reported a position in PFE in Q3 2015 and held it in 12 quarters. The position peaked at $8.16M in Q3 2015. 2,524 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

NumerixS Investment Technologies reported no remaining Pfizer position as of Q4 2019 after selling out during the quarter.
NumerixS Investment Technologies sold 89,496 Pfizer shares in Q4 2019, an estimated $3.05M.
NumerixS Investment Technologies first reported a position in Pfizer in Q3 2015 and held it in 12 quarters.
NumerixS Investment Technologies's Pfizer position peaked at $8.16M in Q3 2015.
2,524 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on NumerixS Investment Technologies's 13F filing for Q4 2019, filed 12 Feb 2020.